About the Startup
Ultromics is a pioneer in AI-driven cardiology diagnostics solutions, offering the first FDA-cleared, Medicare-reimbursed AI technology to help clinicians detect Heart Failure with Preserved Ejection Fraction (HFpEF) and cardiac amyloidosis.
Source: https://tech.eu/2025/07/31/ultromics-raises-55m-series-c-to-scale-ai-driven-heart-failure-detection/
Frequently Asked Questions
What type of funding round did Ultromics raise?
Ultromics raised a series-c round.
How much did Ultromics raise in its series-c?
Ultromics raised $55,000,000 USD in its series-c.
When did Ultromics raise its series-c?
Ultromics raised its series-c on 2025-07-31.
Who invested in Ultromics's series-c?
The investors in Ultromics's series-c are: Oxford Science Enterprises, GV, Blue Venture Fund, University of Chicago Medicine, UPMC Enterprises, Lightrock, Allegis Capital.
What type of investment was Ultromics's series-c?
Ultromics's series-c was a equity investment.